Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Lara Šošić, Marta Paolucci, Stephan Flory, Fadi Jebbawi, Thomas M. Kündig & Pål Johansen. (2023) Allergen immunotherapy: progress and future outlook. Expert Review of Clinical Immunology 19:7, pages 745-769.
Read now
Read now
Marco Caminati, Anna Rita Dama, Ivana Djuric, Marcello Montagni, Michele Schiappoli, Erminia Ridolo, Gianenrico Senna & Giorgio Walter Canonica. (2015) Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety. Expert Review of Clinical Immunology 11:2, pages 233-245.
Read now
Read now
Martin Rosewich, Denise Lee & Stefan Zielen. (2013) Pollinex Quattro: An innovative four injections immunotherapy In allergic rhinitis. Human Vaccines & Immunotherapeutics 9:7, pages 1523-1531.
Read now
Read now
Shaherin Basith, Balachandran Manavalan, Gwang Lee, Sang Geon Kim & Sangdun Choi. (2011) Toll-like receptor modulators: a patent review (2006 – 2010). Expert Opinion on Therapeutic Patents 21:6, pages 927-944.
Read now
Read now
Antu K Dey & Indresh K Srivastava. (2011) Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens. Expert Review of Vaccines 10:2, pages 227-251.
Read now
Read now
Linda Cox & Moises A. Calderon. (2010) Subcutaneous specific immunotherapy for seasonal allergic rhinitis: a review of treatment practices in the US and Europe. Current Medical Research and Opinion 26:12, pages 2723-2733.
Read now
Read now
Sandra M Gawchik & Consuelo L Saccar. (2009) Pollinex Quattro Tree: allergy vaccine. Expert Opinion on Biological Therapy 9:3, pages 377-382.
Read now
Read now
Reto Crameri. (2007) Allergy vaccines: dreams and reality. Expert Review of Vaccines 6:6, pages 991-999.
Read now
Read now
Articles from other publishers (39)
Jonaid Ahmad Malik, Gurpreet Kaur & Javed N. Agrewala. (2023) Revolutionizing medicine with toll-like receptors: A path to strengthening cellular immunity. International Journal of Biological Macromolecules 253, pages 127252.
Crossref
Crossref
Scott Fiala & Howard B Fleit. (2023) Clinical and experimental treatment of allergic asthma with an emphasis on allergen immunotherapy and its mechanisms. Clinical and Experimental Immunology 212:1, pages 14-28.
Crossref
Crossref
Fabiana Furci, Marco Caminati, Ernesto Crisafulli, Gianenrico Senna & Sebastiano Gangemi. (2023) The intriguing possibility of using probiotics in allergen-specific immunotherapy. World Allergy Organization Journal 16:2, pages 100751.
Crossref
Crossref
Jennifer Zimmermann, Alexandra Goretzki, Clara Meier, Sonja Wolfheimer, Yen-Ju Lin, Hannah Rainer, Maren Krause, Saskia Wedel, Gerd Spies, Frank Führer, Stefan Vieths, Stephan Scheurer & Stefan Schülke. (2022) Modulation of dendritic cell metabolism by an MPLA-adjuvanted allergen product for specific immunotherapy. Frontiers in Immunology 13.
Crossref
Crossref
Despo Chatzikleanthous, Derek T. O’Hagan & Roberto Adamo. (2021) Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines. Molecular Pharmaceutics 18:8, pages 2867-2888.
Crossref
Crossref
Paxton Loke, Adriana Chebar Lozinsky, Francesca Orsini, Lydia Su-Yin Wong, Agnes Sze-Yin Leung, Elizabeth Huiwen Tham, Andreas L Lopata, Lynette Pei-Chi Shek & Mimi LK Tang. (2021) Study protocol of a phase 2, dual-centre, randomised, controlled trial evaluating the effectiveness of probiotic and egg oral immunotherapy at inducing desensitisation or sustained unresponsiveness (remission) in participants with egg allergy compared with placebo (Probiotic Egg Allergen Oral Immunotherapy for Treatment of Egg Allergy: PEAT study). BMJ Open 11:7, pages e044331.
Crossref
Crossref
Beatriz León & Andre Ballesteros-Tato. (2021) Modulating Th2 Cell Immunity for the Treatment of Asthma. Frontiers in Immunology 12.
Crossref
Crossref
Marina Luchner, Sören Reinke & Anita Milicic. (2021) TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases. Pharmaceutics 13:2, pages 142.
Crossref
Crossref
José Fernando Florido-López, Carmen Andreu-Balaguer, Carmelo Escudero, Marta Seoane-Rodríguez, Mercedes Hernández, Luis Ángel Navarro-Seisdedos, Miguel Torrecillas-Toro, Mónica Anton-Girones, Leticia Herrero-Lifona, Dorimar Brugaletta, Jesús Macías, Rafael Pineda, Maria Ángeles Lara, Julián López-Caballero & Maria José Rojas. (2020) Effectiveness and safety of a glutaraldehyde-modified, L-tyrosine-adsorbed and monophosphoryl lipid A-Adjuvanted allergen immunotherapy in patients with allergic asthma sensitized to olive pollen: A retrospective, controlled real-world study. World Allergy Organization Journal 13:12, pages 100487.
Crossref
Crossref
Sahra Bashiri, Prashamsa Koirala, Istvan Toth & Mariusz Skwarczynski. (2020) Carbohydrate Immune Adjuvants in Subunit Vaccines. Pharmaceutics 12:10, pages 965.
Crossref
Crossref
Litty Johnson, Albert Duschl & Martin Himly. (2020) Nanotechnology-Based Vaccines for Allergen-Specific Immunotherapy: Potentials and Challenges of Conventional and Novel Adjuvants under Research. Vaccines 8:2, pages 237.
Crossref
Crossref
Patrick Rizk, Mario Rodenas & Anna De Benedetto. (2019) Allergen Immunotherapy and Atopic Dermatitis: the Good, the Bad, and the Unknown. Current Allergy and Asthma Reports 19:12.
Crossref
Crossref
Frank Blanco-Pérez, Alexandra Goretzki, Sonja Wolfheimer & Stefan Schülke. (2019) The vaccine adjuvant MPLA activates glycolytic metabolism in mouse mDC by a JNK-dependent activation of mTOR-signaling. Molecular Immunology 106, pages 159-169.
Crossref
Crossref
Natasha C. Gunawardana & Stephen R. Durham. (2018) New approaches to allergen immunotherapy. Annals of Allergy, Asthma & Immunology 121:3, pages 293-305.
Crossref
Crossref
O Pfaar, U Pieper-Fürst & R Mösges. (2018) Ultra-short-course booster allergen immunotherapy. Immunotherapy 10:7, pages 525-528.
Crossref
Crossref
O. Pfaar, S. Lang, U. Pieper‐Fürst, A. Astvatsatourov, F. Gerich, L. Klimek, M. F. Kramer, Y. Reydelet, K. Shah‐Hosseini & R. Mösges. (2017) Ultra‐short‐course booster is effective in recurrent grass pollen‐induced allergic rhinoconjunctivitis. Allergy 73:1, pages 187-195.
Crossref
Crossref
Stefan Schülke, Lothar Vogel, Ann-Christine Junker, Kay-Martin Hanschmann, Adam Flaczyk, Stefan Vieths & Stephan Scheurer. (2016)
A Fusion Protein Consisting of the Vaccine Adjuvant Monophosphoryl Lipid A and the Allergen Ovalbumin Boosts Allergen-Specific Th1, Th2, and Th17 Responses
In Vitro
. Journal of Immunology Research 2016, pages 1-8.
Crossref
Crossref
Kai Schulze, Thomas Ebensen, Peggy Riese, Blair Prochnow, Claus-Michael Lehr & Carlos A. Guzmán. 2016. How to Overcome the Antibiotic Crisis. How to Overcome the Antibiotic Crisis
207
234
.
S. Schülke, A. Flaczyk, L. Vogel, N. Gaudenzio, I. Angers, B. Löschner, S. Wolfheimer, I. Spreitzer, S. Qureshi, M. Tsai, S. Galli, S. Vieths & S. Scheurer. (2015) MPLA shows attenuated pro-inflammatory properties and diminished capacity to activate mast cells in comparison with LPS. Allergy 70:10, pages 1259-1268.
Crossref
Crossref
Ekaterini Tiligada, Masaru Ishii, Carlo Riccardi, Michael Spedding, Hans-Uwe Simon, Mauro Martins Teixeira, Mario Landys Chovel Cuervo, Stephen T Holgate & Francesca Levi-Schaffer. (2015) The expanding role of immunopharmacology: IUPHAR Review 16. British Journal of Pharmacology 172:17, pages 4217-4227.
Crossref
Crossref
Michelle L. North, Mena Soliman, Terry Walker, Lisa M. Steacy & Anne K. Ellis. (2015) Controlled Allergen Challenge Facilities and Their Unique Contributions to Allergic Rhinitis Research. Current Allergy and Asthma Reports 15:4.
Crossref
Crossref
Deborah A. Garside, Reinaldo Acevedo, Manal Alsaadi, Natalie Nimmo, Ayman Gebril, Dimitrios Lamprou, Alexander B. Mullen & Valerie A. Ferro. 2015. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies
221
250
.
Piyush Patel, Tom Holdich, Karl J. Fischer von Weikersthal-Drachenberg & Birgit Huber. (2014) Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen. Journal of Allergy and Clinical Immunology 133:1, pages 121-129.e2.
Crossref
Crossref
Anne K. Ellis, Michelle L. North, Terry Walker & Lisa M. Steacy. (2013) Environmental exposure unit: a sensitive, specific, and reproducible methodology for allergen challenge. Annals of Allergy, Asthma & Immunology 111:5, pages 323-328.
Crossref
Crossref
Giuseppe Mastrangelo, Emanuela Fadda & Luca Cegolon. (2013) Endotoxin and cancer chemo-prevention. Cancer Epidemiology 37:5, pages 528-533.
Crossref
Crossref
Nicola Scichilone, Vincenza Scalici, Rita Arrigo & Vincenzo Bellia. (2013)
Clinical and anti-inflammatory effects of ultra-short preseasonal vaccine to
Parietaria
in asthma
. Therapeutic Advances in Respiratory Disease 7:4, pages 207-215.
Crossref
Crossref
Mona Hedayat, Kiyoshi Takeda & Nima Rezaei. (2010) Prophylactic and therapeutic implications of toll‐like receptor ligands. Medicinal Research Reviews 32:2, pages 294-325.
Crossref
Crossref
J. Ring & J. Gutermuth. (2011) 100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT). Allergy 66:6, pages 713-724.
Crossref
Crossref
Tunc AkkocMübeccel AkdisCezmi A. Akdis. (2011) Update in the Mechanisms of Allergen-Specific Immunotheraphy. Allergy, Asthma and Immunology Research 3:1, pages 11.
Crossref
Crossref
Soo-Kweon Koo. (2010) Current Update of Pediatric Allergic Rhinitis. Journal of Clinical Otolaryngology Head and Neck Surgery 21:1, pages 33-40.
Crossref
Crossref
Martin Rosewich. (2010) Ultra-short course immunotherapy in children and adolescents during a 3-yrs post-marketing surveillance study. Pediatric Allergy and Immunology 21:1-Part-II, pages e185-e189.
Crossref
Crossref
Olga Borges, Filipa Lebre, Dulce Bento, Gerrit Borchard & Hans E. Junginger. (2009) Mucosal Vaccines: Recent Progress in Understanding the Natural Barriers. Pharmaceutical Research 27:2, pages 211-223.
Crossref
Crossref
Ol'ga Valer'evna Trusova, I M Gayduk, D S Korostovtsev, О V Trusova, I M Gaiduk & D S Korostovtsev. (2009) Allergen-specific immunotherapy in children, and the perspectives of the method. Russian Journal of Allergy 6:4, pages 58-66.
Crossref
Crossref
Mübeccel Akdis & Cezmi A. Akdis. (2009) Therapeutic manipulation of immune tolerance in allergic disease. Nature Reviews Drug Discovery 8:8, pages 645-660.
Crossref
Crossref
Jennifer M. Rolland, Leanne M. Gardner & Robyn E. O'Hehir. (2009) Allergen-related approaches to immunotherapy. Pharmacology & Therapeutics 121:3, pages 273-284.
Crossref
Crossref
Dragana Stanic, Lidija Burazer, Marija Gavrovic-Jankulovic, Ratko JankovM.M. & Tanja Cirkovic-Velickovic. (2009) Chemical modification of Art v 1, a major mugwort pollen allergen, by cis-aconitylation and citraconylation. Journal of the Serbian Chemical Society 74:4, pages 359-366.
Crossref
Crossref
Giovanni Passalacqua & Giorgio Walter Canonica. 2010. Allergy Frontiers: Therapy and Prevention. Allergy Frontiers: Therapy and Prevention
195
215
.
Thomas Ebensen & Carlos A. Guzmán. 2009. Pharmaceutical Biotechnology. Pharmaceutical Biotechnology
171
188
.
J. Bousquet, N. Khaltaev, A. A. Cruz, J. Denburg, W. J. Fokkens, A. Togias, T. Zuberbier, C. E. Baena-Cagnani, G. W. Canonica, C. Van Weel, I. Agache, N. Aït-Khaled, C. Bachert, M. S. Blaiss, S. Bonini, L.-P. Boulet, P.-J. Bousquet, P. Camargos, K.-H. Carlsen, Y. Chen, A. Custovic, R. Dahl, P. Demoly, H. Douagui, S. R. Durham, R. Gerth Van Wijk, O. Kalayci, M. A. Kaliner, Y.-Y. Kim, M. L. Kowalski, P. Kuna, L. T. T. Le, C. Lemiere, J. Li, R. F. Lockey, S. Mavale-Manuel, E. O. Meltzer, Y. Mohammad, J. Mullol, R. Naclerio, R. E. O’Hehir, K. Ohta, S. Ouedraogo, S. Palkonen, N. Papadopoulos, G. Passalacqua, R. Pawankar, T. A. Popov, K. F. Rabe, J. Rosado-Pinto, G. K. Scadding, F. E. R. Simons, E. Toskala, E. Valovirta, P. Van Cauwenberge, D.-Y. Wang, M. Wickman, B. P. Yawn, A. Yorgancioglu, O. M. Yusuf, H. Zar, I. Annesi-Maesano, E. D. Bateman, A. Ben Kheder, D. A. Boakye, J. Bouchard, P. Burney, W. W. Busse, M. Chan-Yeung, N. H. Chavannes, A. Chuchalin, W. K. Dolen, R. Emuzyte, L. Grouse, M. Humbert, C. Jackson, S. L. Johnston, P. K. Keith, J. P. Kemp, J.-M. Klossek, D. Larenas-Linnemann, B. Lipworth, J.-L. Malo, G. D. Marshall, C. Naspitz, K. Nekam, B. Niggemann, E. Nizankowska-Mogilnicka, Y. Okamoto, M. P. Orru, P. Potter, D. Price, S. W. Stoloff, O. Vandenplas, G. Viegi & D. Williams. (2008) Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*. Allergy 63, pages 8-160.
Crossref
Crossref